{
  "pmcid": "12385231",
  "sha256": "b31dbd5d37879d2665954bd2f8e1fd50634f7e61b28ded2a1f82044ab4a3be07",
  "timestamp_utc": "2025-11-09T23:35:43.788761+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.62204301075269,
    "reading_ease": 29.108620071684584,
    "word_count": 248
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial of Pain Education and Exercise Training in Primary Dysmenorrhea"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly assigned to PNE+ET or BPE+ET groups."
      },
      "Participants": {
        "score": 2,
        "evidence": "The study included nulligravid volunteers aged 18 years and older diagnosed with PD, conducted at a physiotherapy and rehabilitation department."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly assigned to PNE+ET or BPE+ET groups."
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial aimed to evaluate the effects of pain neuroscience education (PNE) versus biomedical pain education (BPE), both combined with exercise training (ET), on primary dysmenorrhea (PD)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was menstrual pain intensity, assessed over two menstrual cycles."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using an online tool with a block size of six, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 38 participants were randomised: 19 to PNE+ET and 19 to BPE+ET, between January 2022 and June 2022."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "All participants were analysed using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "PNE+ET resulted in greater reductions in menstrual pain, central sensitization symptoms, and pain catastrophizing compared to BPE+ET (p < 0.05, Cohen’s d = 0.683–1.174)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT06040866."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}